57°
Feels Like: 57°
49°
76°
56°
By Jonathan Stempel NEW YORK (Reuters) - A U.S. appeals court on Wednesday said that some emergency contraception pills now can be s...
Read More »(Reuters) - Celgene Corp said on Wednesday that its flagship blood cancer drug, Revlimid, was approved by U.S. health regulators to ...
Read More »By Kerry Grens NEW YORK (Reuters Health) - Kids who don't get vaccines when they see their pediatrician for a sick visit - despite b...
Read More »
By David Morgan WASHINGTON (Reuters) - U.S. health advisers voted on Thursday to recommend relaxing market restrictions on GlaxoSmit...
Read More »MUMBAI (Reuters) - Drugmaker Cadila Healthcare Ltd received regulatory approval to market a new diabetes drug in India that it devel...
Read More »
ZURICH (Reuters) - Novartis said studies show its Gilenya drug helped keep patients with multiple sclerosis free of the disease. The...
Read More »
ZURICH (Reuters) - Novartis said studies show its Gilenya drug helped keep patients with multiple sclerosis free of the disease. The...
Read More »
By Ben Hirschler LONDON (Reuters) - Genomics and particle physics - offering different perspectives on the fundamental nature of lif...
Read More »By Deena Beasley (Reuters) - An exciting class of new cancer drugs may boost patients' odds for survival, but healthcare providers a...
Read More »(Reuters) - Johnson & Johnson is voluntarily recalling about 32 million packages of its birth control pill Cilest in Europe, Asia an...
Read More »
